This page includes the latest FDA filings for Dr Madhav Pai. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2023-02-09 |
Aspire Pharmaceuticals Inc, Dr Madhav Pai | Otc Medication | 2023-02-09 |
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2023-02-08 |
Aspire Pharmaceuticals Inc, Dr Madhav Pai | Otc Medication | 2023-02-08 |
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2023-01-11 |
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2022-04-14 |
Aspire Pharmaceuticals Inc, Dr Madhav Pai | Otc Medication | 2022-04-14 |
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2021-05-29 |
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2021-04-01 |
Aspire Pharmaceuticals Inc., Dr Madhav Pai | Otc Medication | 2021-03-20 |